SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-014594
Filing Date
2017-03-07
Accepted
2017-03-07 07:53:40
Documents
7
Effectiveness Date
2017-03-07

Document Format Files

Seq Description Document Type Size
1 8-K a17-2335_48k.htm DEFA14A 37460
2 EX-99.1 a17-2335_4ex99d1.htm EX-99.1 25128
3 EX-99.2 a17-2335_4ex99d2.htm EX-99.2 14630
4 GRAPHIC g23354moi001.gif GRAPHIC 131908
5 GRAPHIC g23354moi002.gif GRAPHIC 180889
6 GRAPHIC g23354moi003.gif GRAPHIC 141316
7 GRAPHIC g23354mmi001.jpg GRAPHIC 2107
  Complete submission text file 0001104659-17-014594.txt   707255
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17669627
SIC: 2834 Pharmaceutical Preparations